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Different activation of mitogen-activated protein kinases in ex-
perimental proliferative glomerulonephritis. Mitogen-activated
protein (MAP) kinases are critical for cell signaling goals such as
cellular proliferation and induction of apoptosis. We examined
whether MAP kinases, as a point of convergence for multiple
extracellular stimuli, are activated in proliferative glomerulone-
phritis (GN) in vivo. Accelerated crescentic anti-glomerular base-
ment membrane (GBM) GN was induced in rats preimmunized
with rabbit IgG by administration of rabbit anti-rat GBM serum.
Whole cortical tissue and isolated glomeruli were then subjected
to kinase activity assays and Western blot analysis. Cortical
activity of the archetypal MAP kinase, extracellular signal-regu-
lated kinase (ERK), was increased significantly one, three, and
seven days after induction of GN. In contrast, activation of MAP
kinases with antiproliferative actions, stress-activated protein
kinase, and p38 MAP kinase was detectable only in the early
stages of proliferative GN (days one and three), implying that
different MAP kinases serve distinct roles in the pathogenesis of GN.
A major focus for research into the pathogenesis of
glomerulonephritis (GN) has been to define extracellular
growth-promoting factors controlling cell growth during
proliferative forms of GN. Several cytokines are implicated
in the pathogenesis of proliferative GN and may account
for hypercellularity [1]. Mitogen-activated protein (MAP)
kinases are important mediators in the intracellular net-
work of interacting proteins transducing extracellular cues
to intracellular responses [2]. Because in vitro studies have
shown MAP kinases to be a key point in the control of
cellular growth, these might be crucial mediators of cellular
proliferation in renal diseases mediated by extracellular
stimuli. Extracellular signal-regulated kinase (ERK), the
best described mammalian MAP kinase, regulates the
expression of many genes by phosphorylating several tran-
scription factors [2]. ERK’s activity is regulated by MAP
kinase/ERK kinase (MEK), which phosphorylates both
threonine and tyrosine regulatory sites in ERK [2]. In vitro
studies have established the pivotal role of the ERK
signaling pathway in the control of cellular proliferation [2].
In contrast to ERK, the recently described MAP kinases
stress-activated protein kinase (SAPK) and p38 MAP ki-
nase are thought to inhibit cell growth and to induce
apoptosis [2, 3]. Although much is known about the func-
tion of MAP kinases in vitro, little is known about their role
in physiological or pathophysiological conditions or their
activation in vivo.
METHODS
Proliferative GN was induced as described previously [4].
Briefly, male Sprague-Dawley rats (180 to 200 g) were
immunized with 1-mg i.p. rabbit IgG emulsified in complete
Freund’s adjuvant. On days 5 and 6 thereafter, animals
were given rabbit immune serum raised against rat partic-
ulate glomerular basement membrane (GBM) or control
nonimmune rabbit serum, via the tail vein. Studies were
performed on days 1, 3, and 7 following the second
injection. Renal cortical sections and isolated glomeruli
were lysed in Triton X-100 buffer.
Western blot analysis was performed as described previ-
ously [5]. Briefly, soluble lysate (30 mg) of whole cortical
tissue or isolated glomeruli were mixed with Laemmli
buffer and were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Cellulo-
ses were probed with polyclonal antibodies against p42
ERK and phosphorylated p38 MAP kinase (New England
Biolabs, Beverly, MA, USA) or with monoclonal antibodies
against MEK-1 (Transduction Laboratories, Lexington,
KY, USA).
Kinase activity assays were performed as described pre-
viously [5]. Briefly, 200-mg soluble lysate was incubated for
90 minutes with 2-ml polyclonal antibody recognizing p42
ERK. Immunocomplexes were adsorbed on protein A-
sepharose and were washed and resuspended in a 60-ml
kinase buffer containing 50 mM adenosine triphosphate
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(ATP), 5-mCi [g-32P]ATP, and 15-mg myelin basic protein.
The reaction was initiated by incubation at 30°C for 15
minutes. Laemmli buffer was added to terminate the
reaction, and samples were subjected to SDS-PAGE.
RESULTS AND DISCUSSION
We evaluated the in vivo activity of MAP kinases in the
kidney of rats with crescentic GN. Sprague-Dawley rats
developed accelerated GN with heavy proteinuria as early
as one day following the anti-GBM antibody injections [4].
Prominent lesions of proliferation and crescent formation
were apparent as early as day 3 [4], and most animals died
by days 9 to 11. We examined the activation of ERK on
days 1, 3, and 7 in whole cortical tissue. Anti-ERK Western
blot analysis and immunocomplex ERK activity assays
showed a slight increase in activation of ERK on day 1 and
significant activation on days 3 and 7 (Fig. 1). Quantifica-
tion of myelin basic protein phosphorylation at day 3
revealed a fourfold increase in ERK activity in rats injected
with anti-GBM immune serum. Cellular proliferation is
thought to be pivotal for the development of crescent
formation and progression of proliferative GN to end-stage
renal disease. The proliferative response to injury in GN
may be augmented by convergence of multiple cytokines on
ERK, inducing its activation.
Previously, up-regulation of MEK protein levels, the
kinase upstream from ERK, has been thought to be
important in the long-term regulation of ERK in cultured
glomerular mesangial cells [6]. Here, we show up-regula-
tion of MEK protein levels in rats with experimental
proliferative GN. As shown in Figure 2, the changes of
MEK protein in whole cortex samples were not significant.
However, in isolated glomeruli, there was a dramatic
increase in MEK protein at day 3 and day 7. Thus, in
agreement with the location of the prominent cellular
proliferation, MEK protein levels were found elevated
principally in glomeruli. It is therefore likely that the
elevated MEK protein levels contribute to ERK activation
in vivo.
Previously, we have shown SAPK to be activated only
early in the development of proliferative GN [4]. SAPK and
p38 MAP kinase have recently been suggested to induce
cellular apoptosis and to inhibit cellular proliferation [2, 3].
Figure 3 shows the activation of p38 MAP kinase in isolated
glomeruli on days 1 and 3, but not on day 7, implying
involvement of p38 MAP kinase only in the early stage in
Fig. 1. Activation of extracellular signal-regulated kinase (ERK) in crescentic glomerulonephritis (GN). Upper panel: Western blot analysis shows
ERK2 [p42 mitogen-activated protein (MAP) kinase] in whole cortical tissue lysates. At each time point, one control and one experimental animal were
studied. Rats were sacrificed at the indicated times following the second injection of anti-glomerular basement membrane (GBM) serum. Activation
of ERK is identifiable by an increase of phosphorylated protein forms, detected by bands with delayed mobility (indicated by stars), compared with the
unshifted unphosphorylated ERK forms. Lower panels: ERK activity assayed by the ability of immunoprecipitated ERK to phosphorylate myelin basic
protein (MBP).
Fig. 2. Western blot analysis of MAP kinase/
ERK kinase (MEK) protein expression in
cortical and glomerular lysates.
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the pathogenesis of this disease model. No significant
changes of p38 MAP kinase activity were seen in whole
cortical tissue, pointing to the glomeruli as the major site of
p38 MAP kinase activation during early stages of prolifer-
ative GN. Mesangial cell apoptosis occurs during anti-Thy1
GN and is thought to account for the resolution of glomer-
ular hypercellularity in this disease model [7]. It is, there-
fore, tempting to speculate that the observed p38 MAP
kinase activation might account for a similar induction of
apoptosis in proliferative GN. However, further studies are
needed for a better understanding of the role of p38 MAP
kinase and SAPK in crescentic GN.
Activation of ERK and p38 MAP kinase in proliferative
GN, as shown in this study, is a novel finding and points to
MAP kinases as a putative regulator of the proliferative
response to immune injury in vivo. Activation of p38 MAP
kinase follows a different time course to that of ERK,
suggesting distinct roles for these two MAP kinases roles at
different stages of proliferative GN.
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APPENDIX
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MEK, MAP kinase/ERK kinase; SAPK, stress-activated protein kinase.
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Fig. 3. Activation of p38 mitogen-activated protein (MAP) kinase in crescentic glomerulonephritis (GN). At each time point, one control and two
experimental animal were studied. Whole lysates of isolated glomeruli were analyzed by Western blot analysis employing an antiserum against the
phosphorylated and activated form of p38 MAP kinase.
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